首页> 外文期刊>Journal of Oncological Sciences >Tumor markers of breast cancer: New prospectives
【24h】

Tumor markers of breast cancer: New prospectives

机译:乳腺癌的肿瘤标志物:新观点

获取原文
       

摘要

Tumor markers are substances produced by the tumors or by other cells of the body in response to cancer or certain benign conditions. Although most of these markers are made by the normal cells as well as by cancer cells, they are produced at much higher levels in cancerous conditions. These markers are used to evaluate the patient's response to treatment and to detect the presence of metastasis or recurrence. Breast cancer is one of the most common malignancies in females worldwide. The CA 27-29, CA 15-3, CA27.29, carcinoembryonic antigen, tissue polypeptide specific antigen, p53, cathepsin D, cyclin E, nestin and HER-2 are tumor markers that are often expressed in people with breast cancer. They play a crucial role in diagnosis, monitoring response to therapy, early detection of metastasis and determination of recurrence in patients with breast cancer.
机译:肿瘤标记物是由肿瘤或人体其他细胞响应癌症或某些良性状况而产生的物质。尽管这些标记物中的大多数是由正常细胞以及癌细胞产生的,但它们在癌性疾病中的产生水平要高得多。这些标记物用于评估患者对治疗的反应,并检测是否存在转移或复发。乳腺癌是全世界女性中最常见的恶性肿瘤之一。 CA 27-29,CA 15-3,CA27.29,癌胚抗原,组织多肽特异性抗原,p53,组织蛋白酶D,细胞周期蛋白E,巢蛋白和HER-2是经常在乳腺癌患者中表达的肿瘤标志物。它们在乳腺癌患者的诊断,监测治疗反应,及早发现转移灶以及确定复发中起着至关重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号